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Abstract
Background The objective of the current study was to investigate both short- and long-term outcomes of patients undergoing
curative-intent resection for intrahepatic cholangiocarcinoma (ICC) stratified by extent of hepatic resection relative to overall
final pathological margin status.
Methods One thousand twenty-three patients with ICC who underwent curative-intent resection were identified from a multi-
institutional database. Demographic, clinicopathological, and operative data, as well as overall (OS) and recurrence-free survival
(RFS) were compared among patients undergoing major and minor resection before and after propensity score matching.
Results Overall, 608 (59.4%) patients underwent major hepatectomy, while 415 (40.6%) had aminor resection.Major hepatectomy
was more frequently performed among patients who had large, multiple, and bilobar tumors. Roughly half of patients (n = 294,
48.4%) developed a postoperative complication following major hepatectomy versus only one fourth of patients (n = 113, 27.2%)
after minor resection (p < 0.001). In the propensity model, patients who underwent major hepatectomy had an equivalent OS and
RFS versus patients who had a minor hepatectomy (median OS, 38 vs. 37 months, p = 0.556; and median RFS, 20 vs. 18 months,
p = 0.635). Patients undergoing major resection had comparable OS and RFS with wide surgical margin (≥10 and 5–9 mm), but
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improved RFS when surgical margin was narrow (1–4 mm) versus minor resection in the propensity model. In the Cox regression
model, tumor characteristics and surgical margin were independently associated with long-term outcome.
Conclusions Major hepatectomy for ICC was not associated with an overall survival benefit, yet was associated with increased
perioperative morbidity. Margin width, rather than the extent of resection, affected long-term outcomes. Radical parenchymal-
sparing resection should be advocated if a margin clearance of ≥5 mm can be achieved.
Keywords Intrahepaticcholangiocarcinoma .Major .Minor .
Hepatectomy . Outcomes
Introduction
Intrahepatic cholangiocarcinoma (ICC) is the second most
common type of primary liver cancer after hepatocellular car-
cinoma (HCC), accounting for 5–30% of all primary hepatic
malignancies.1–3 ICC originates from malignant transforma-
tion of intrahepatic biliary epithelial cells. While rare, the in-
cidence of ICC has increased from 0.44 to 1.18 cases per
100,000 between 1973 and 2012 in the USA with the inci-
dence continuing to increase worldwide.4 The rise in the re-
ported number of ICC cases is undoubtedly multifactorial and
may be due to better imaging, more disease-specific histopath-
ologic techniques, as well as an increase in the prevalence of
certain risk factors.4,5 While rare, ICC is an aggressive disease
with outcomes that are typically worse than HCC.5,6
For patients with ICC, hepatic resection remains the best
therapeutic approach; however, less than 40% of ICC patients
are potential candidates for resection due to advanced disease
at presentation.5,7 Among patients who are candidates for sur-
gery, 5-year survival following curative-intent resection
ranges from only 30 to 50%.2 Both biological and technical
factors are associated with survival after resection of ICC. In
particular, lymph node metastasis, tumor size, number, and
grade are all associated with long-term outcomes.8–11 In addi-
tion, our group had previously reported that R1 margin status
was associated with inferior long-term outcomes.8 In fact, we
reported that there was an incremental worsening of
recurrence-free and overall survival as margin width de-
creased. Obtaining a wider surgical margin often necessitates,
however, a more extensive hepatic resection. While major
hepatectomy, defined as resection of three or more liver
segments,12 may facilitate a wider surgical margin and poten-
tial removal of tumor-bearing portal tributaries, perioperative
morbidity and mortality may be higher compared with minor
resection.13–15 While previous studies have advocated for pa-
renchymal sparing, minor resections for diseases such as co-
lorectal liver metastasis, other reports have noted an improve-
ment in outcomes following large, anatomic resections of oth-
er diseases such as HCC.13,16–18 The impact of resection ex-
tent, specifically the type of liver resection (i.e., minor vs.
major), on outcomes following resection of ICC has not been
examined. Given the lack of data on long-term outcomes
following minor versus major hepatectomy for ICC, the ob-
jective of the current study was to investigate both short- and
long-term outcomes stratified by extent of hepatic resection
relative to overall final pathological margin status. In addition,
we sought to define the relative survival benefit of achieving
additional margin width compared with any potential detri-
mental complication-related effects on long-term prognosis.
Materials and Methods
Study Population
A multi-institutional database consisting of 1142 patients un-
dergoing curative-intent hepatic resection for ICC from 1990
to 2016 at 14 major hepatobiliary centers in America, Europe,
Australia, and Asia were identified. The 14 medical centers
included The Ohio State University, Columbus, OH;
Stanford University, Stanford, CA; University of Virginia,
Charlottesville, VA; Emory University, Atlanta, GA; Fundeni
Clinical Institute of Digestive Disease, Bucharest, Romania;
Johns Hopkins Hospital, Baltimore, MD; Curry Cabral
Hospital, Lisbon, Portugal; Ospedale San Raffaele, Milan,
Italy; Royal Prince Alfred Hospital, University of Sydney,
Sydney, Australia; Eastern Hepatobiliary Surgery Hospital,
Shanghai, China; Beaujon Hospital, Clichy, France;
University of Ottawa, Ottawa, Ontario, Canada; Erasmus
University Medical Centre, Rotterdam, Netherlands; and
Yokohama City University School of Medicine, Yokohama,
Japan. All patients were diagnosed with ICC as confirmed by
histological examination. Patients with extrahepatic metastasis
were excluded. Patients undergoing an R2 resection (n = 13),
ablation only (n = 2), or other intra-arterial therapies (n = 15)
were also excluded. Moreover, 89 patients with insufficient
details on resection type and/or survival time were excluded.
After excluding patients based on these criteria, 1023 patients
remained in the analytic cohort. The Institutional Review
Board of each participating institution approved the study.
Data Collection
Demographic and clinicopathologic data were collected for
each patient including age, gender, ethnicity, American
Society of Anesthesiologists (ASA) score, body mass index
(BMI), as well as the presence of clinical jaundice or liver
cirrhosis. Operative details included type and extent of
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hepatectomy, type and extent of vascular resection, receipt of
lymphadenectomy, margin status, operative time, estimated
blood loss, and intraoperative blood transfusion. Tumor size,
number, morphology, vascular/perineural/biliary/adjacent organ
invasion, lymph node metastasis, histological grade, and resec-
tionmargin were ascertained based on the final pathology report.
Types of hepatic resection were defined according to the consen-
sus classification.12Major hepatectomywas defined as the resec-
tion of three or more segments (right hepatectomy, left hepatec-
tomy, extended right hepatectomy, extended left hepatectomy,
and any trisegmentectomy), whereas minor resection included
resection of two or fewer segments and non-anatomic wedge
resection according to the classification of Couinaud.19 Data on
tumor stage were collected according to the American Joint
Committee on Cancer (AJCC) 7th edition staging system.20
Primary outcomes were overall survival (OS) and
recurrence-free survival (RFS), both calculated from the date
of surgery. Recurrence was defined as identification of suspi-
cious imaging findings or biopsy-proven tumor. Recurrent
sites were divided as intrahepatic and/or extrahepatic.
Secondary outcomes were postoperative morbidity and mor-
tality at 30 and 90 days following surgery. Postoperative com-
plications were graded according to the Clavien-Dindo classi-
fication (CDC) of surgical complication.21
Statistical Analysis
Numerical variables were expressed as medians with inter-
quartile ranges (IQR) and compared with student t test or
Mann-Whitney U test between the two groups. Nominal var-
iables were expressed as number and percentages and com-
pared with Chi-squared test or Fisher’s exact test. Kaplan-
Meier survival analyses were used to compare survival using
the log-rank test between any two groups. Potential risk fac-
tors associated with OS and RFS were identified using
Table 1 Demographic and clinicopathological characteristics of










Age (years) 57 (48–65) 61 (53–69) <0.001
Sex <0.001
Male 259 (62.4%) 310 (51.0%)
Female 156 (37.6%) 297 (48.8%)
Race <0.001
White 136 (32.8%) 403 (66.3%)
Black 7 (1.7%) 28 (4.6%)
Asian 265 (63.9%) 134 (22.0%)
Other 2 (0.5%) 20 (3.3%)
Missing 5 (1.2%) 22 (3.6%)
Body mass index 24.8 (22.1–27.8) 25.3 (22.5–28.0) 0.243
Clinical jaundice
present
13 (3.1%) 89 (14.6%) <0.001
Liver cirrhosis 88 (21.2%) 20 (3.3%) <0.001
Carbohydrate antigen
19–9 (U/mL)
27.0 (11.2–86.4) 88.0 (24.8–341.3) <0.001
Carcinoembryonic
antigen (ng/mL)
2.3 (1.4–3.5) 2.4 (1.3–4.6) 0.257
Tumor size (cm) 5.0 (3.6–7.3) 7.0 (4.7–9.5) <0.001
Multiple lesions (≥2) 51 (12.3%) 125 (20.6%) 0.001
Bilobar tumor 40 (9.6%) 150 (24.7%) <0.001
Vascular invasion
Macro 24 (5.8%) 87 (14.3%) <0.001
Micro 57 (13.7%) 224 (36.8%) <0.001
Perineural invasion 25 (6.0%) 133 (21.9%) <0.001
Direct invasion of
adjacent organs
17 (4.1%) 58 (9.5%) 0.001
Biliary invasion 12 (2.9%) 125 (20.6%) <0.001
Satellite lesions 75 (18.1%) 148 (24.3%) 0.021
AJCC T stage <0.001
T1-T2 372 (89.6%) 404 (66.4%)
T3-T4 26 (6.3%) 147 (24.2%)
Missing 17 (4.1%) 57 (9.4%)
AJCC N stage <0.001
N0 268 (64.6%) 294 (48.4%)
N1-N2 40 (9.6%) 138 (22.7%)
Nx 107 (25.8%) 176 (28.9%)
Histological grade <0.001
Well to moderate 365 (88.0%) 446 (73.4%)
Poor to undifferentiated 34 (8.2%) 138 (22.7%)
Missing 16 (3.9%) 24 (3.9%)
Morphological type <0.001
Mass forming 386 (93.0%) 431 (70.9%)
Papillary 9 (2.2%) 19 (3.1%)
Periductal infiltrating 3 (0.7%) 46 (7.6%)
Mass-forming +
periductal infiltrating
6 (1.4%) 66 (10.9%)
Missing 11 (2.7%) 46 (7.6%)
Resection procedure
Wedge resection 161 (38.8%) –
Monosegmentectomy 79 (19.0%) –
Bisegmentectomy 175 (42.2%) –
Trisegmentectomy – 18 (3.0%)
Right hepatectomy – 161 (26.5%)

















Margin distance (mm) <0.001
<1 26 (6.3%) 103 (16.9%)
1–4 157 (37.8%) 192 (31.6%)
5–9 105 (25.3%) 110 (18.1%)
≥10 116 (28.0%) 146 (24.0%)
Missing 11 (2.7%) 57 (9.4%)
Major vascular resection 19 (4.6%) 105 (17.3%) <0.001
Bile duct resection 12 (2.9%) 165 (27.1%) <0.001
Lymphadenectomy 108 (26.0%) 374 (61.5%) <0.001
Intraoperative blood loss 250 (150–445) 600 (300–1025) <0.001
Intraoperative blood
transfusion
55 (13.3%) 210 (34.5%) <0.001
Postoperative blood
transfusion
12 (2.9%) 77 (12.7%) <0.001
Operation time (min) 120 (90–180) 297 (200–420) <0.001
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univariate and multivariable Cox hazard regression models
after exclusion of patients who died within 90 days postoper-
atively (n = 60), and expressed as hazard ratio (HR) and 95%
confidence interval (CI). Factors with p value <0.1 by univar-
iate analysis were included in multivariable analysis.
Since patients who underwent major and minor hepatecto-
my groups were not randomly distributed, propensity score
matching (PSM) was used to mitigate selection bias.
Specifically, variables potentially affecting long-term out-
comes were utilized in the propensity score based on identifi-
cation in logistic regression analysis. Propensity score analysis
with 1:1 matching was performed without replacement using a
caliper with a width 0.1 of the standard deviation to generate
matched pairs of the patients. In all analyses, two-tailed p value
<0.05 was considered statistically significant. Statistical anal-
ysis was carried out using SPSS 22.0 (Chicago, IL, USA).
Results
Baseline Demographic and Clinicopathological
Characteristics
The median age of the 1023 patients with ICC was 59 years
(IQR, 51–68 years); the majority were male (n = 569, 55.6%)
and Caucasian (n = 539, 52.7%). Overall, 608 (59.4%) pa-
tients underwent major hepatectomy, while 415 (40.6%) had
a minor resection. Patients undergoing major hepatectomy
were older, more likely to be female, and more often presented
with clinical jaundice (Table 1). Major hepatectomy was more
frequently performed among patients who had large, multiple,
and bilobar tumors. Patients undergoing major hepatectomy
were also more likely to have advanced disease characterized
by vascular, biliary, perineural, and adjacent tissue invasion,
as well as poor tumor differentiation (Table 1). Interestingly,
patients who underwent a major hepatectomy were more like-
ly to have a microscopically positive (R1) margin than pa-
tients who underwent minor resection (p < 0.001, Table 1).
Association of Resection Extent with Short-
and Long-Term Outcomes
Not surprisingly, major hepatectomy was associated with lon-
ger operative times, a larger volume of intraoperative blood
loss, and more frequent intra- and postoperative transfusion of
packed red blood cells (Table 1). Consequently, almost one half
of patients (n = 294, 48.4%) developed a postoperative compli-
cations following major hepatectomy versus only one fourth of
patients (n = 113, 27.2%) after minor resection (p < 0.001).
Moreover, major complications (CDC III-IV) and postoperative
death (CDC V) were more common after a major versus minor
hepatic resection (both p < 0.01), while minor complications
(CDC I-II) were comparable (p = 0.303, Table 2). Major
hepatectomy was associated with more frequent surgical
technique-related (anastomotic leakage, intra-abdominal ab-
scess, liver failure, cholangitis, and bowel perforation/ileus),
medical (respiratory insufficiency, pulmonary embolism, renal
failure, and cardiac events), and infectious (systemic, urinary
Table 2 Short- and long-term outcome of patients undergoing minor















I 51 (12.3%) 54 (8.9%)
II 32 (7.7%) 84 (13.8%)
III 24 (5.8%) 105 (17.3%)
IV 0 12 (2.0%)




13 (3.1%) 65 (10.7%) <0.001
Intra-abdominal abscess 2 (0.5%) 27 (4.4%) <0.001
Liver abscess 2 (0.5%) 6 (1.0%) 0.484
Cholangitis 0 7 (1.2%) 0.046
Liver failure 3 (0.7%) 24 (3.9%) 0.001
Portal vein thrombosis 0 4 (0.7%) 0.151
Intra-abdominal/GI
bleeding
7 (1.7%) 17 (2.8%) 0.297
Bowel perforation/ileus 1 (0.2%) 9 (1.5%) 0.055
Pulmonary
Pleural effusion 38 (9.2%) 47 (7.7%) 0.422
Pneumothorax 0 3 (0.5%) 0.276
Respiratory
insufficiency
3 (0.7%) 20 (3.3%) 0.008
Pneumonia 7 (1.7%) 12 (2.0%) 0.817
Pulmonary embolism 1 (0.2%) 9 (1.5%) 0.055
Cardiac events 4 (1.0%) 22 (3.6%) 0.008
Urinary
Urinary tract infection 0 13 (2.1%) 0.001
Renal failure 1 (0.2%) 11 (1.8%) 0.034
Systemic sepsis 3 (0.7%) 27 (4.4%) <0.001
Wound
infection/dehiscence
3 (0.7%) 27 (4.4%) <0.001
Other complications 33 (8.0%) 49 (8.1%) 1.000
Readmission within
30 days
5 (1.2%) 43 (7.1%) <0.001
30-day mortality 6 (1.4%) 43 (7.1%) <0.001
90-day mortality 13 (3.1%) 47 (7.7%) 0.002
Tumor recurrence 0.103
Intrahepatic 195 (47.0%) 234 (38.8%)
Extrahepatic 21 (5.1%) 43 (7.1%)
Intra- and extrahepatic 46 (11.1%) 72 (11.8%)
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tract, and wound infection) complications (Table 2). In turn,
readmission and perioperative mortality were higher among
patients after major versus minor hepatectomy (all p < 0.01).
Among all patients, median, 1-, 3-, and 5-year OS was
37 months, 78%, 51%, and 39%, respectively. During follow-
up, 611 (60%) patients experienced a tumor recurrence; medi-
an, 1-, 3-, and 5-year RFSwas 17months, 57%, 36%, and 31%,
respectively. The recurrence site was intrahepatic tumor only in
most patients (n = 429/611; 70%) (Table 2). Interestingly, pa-
tients undergoing major liver resection had a worse OS, yet a
similar RFS compared with patients who underwent a minor
resection (median OS, 34 vs. 49 months, p = 0.004; median
RFS, 16 vs. 19months, p = 0.151; Fig. 1a, b). A Cox regression
model was performed to identify risk factors associated with
overall and recurrence-free survival of 963 patients after exclu-
sion of patients who died within 90 days following surgery
(n = 60). On multivariable analysis, tumor characteristics, sur-
gical margin width, and intraoperative blood transfusion were
associated with OS and RFS, yet not resection extent (major vs.
minor) (Tables 3 and 4).
Given the baseline differences in the minor versus major
hepatectomy cohorts, PSM was then utilized to generate
290 pairs of well-matched patients with similar tumor size,
number, distribution, vascular invasion, surgical margin
width, incidence and severity of postoperative complica-
tions, and in hospital mortality (Supplementary Table 1).
In the propensity model, patients who underwent major hep-
atectomy had equivalent OS and RFS as patients who had a
minor hepatectomy (median OS, 38 vs. 37 months,
p = 0.556; and median RFS, 20 vs. 18 months, p = 0.635,
Fig. 1c, d).
Outcomes of Patients with Different Width of Surgical
Margin
Given that surgical margin may be associated with the extent
of resection, patients who underwent R0 resection were strat-
ified into three groups with different margin width: ≥10, 5–9,
and 1–4 mm. The impact of major versus minor resection on
OS and RFS using PSM was then assessed (Supplementary
Fig. 1 Overall survival (a, c) and recurrence-free survival (b, d) before and after propensity score matching of patients undergoing major and minor
hepatectomy for intrahepatic cholangiocarcinoma
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Table 2). Patients with a wide surgical margin (≥10 or 5–9 mm)
demonstrated no difference in OS and RFS when stratified by
major versus minor resection before and after PSM
(Supplementary Fig. 1A, B, Fig. 2a, b). Interestingly, patients
who underwent amajor resection with a narrow surgical margin
(1–4 mm) had a worse OS (Supplementary Fig. 1C). However,
after PSM, patients who underwent a major hepatectomywith a
narrow surgical margin were noted to have a comparable OS
versus patients undergoing a minor hepatectomy with close
margins. In contrast, patients who underwent a major hepatec-
tomy with close surgical margins had an improved RFS versus
minor resection after matching for tumor characteristics, post-
operative complications, and mortality on PSM (Fig. 2c).
Discussion
Surgical resection is the best curative treatment option for
ICC and may provide patients with a chance for long-term
survival.8,22,23 At the time of surgery, the extent of liver
resection for a liver tumor is typically determined by tumor
size, number, and location, as well as underlying quality of
the non-tumorous liver.24,25 Whether major hepatectomy is
necessary and superior to minor resection in improving the
long-term survival of patients with HCC and CRLM has
been a long-standing topic of interest.13–16,26 Major hepa-
tectomy may be associated with wider surgical margins and
theoretical removal of tumor-bearing portal tributaries, yet
it sacrifices a large volume of functional liver parenchyma
with higher postoperative morbidity and mortality than mi-
nor hepatectomy.13–15 The extent of hepatic resection and
its impact on outcomes among patients with ICC has not
been well examined. The current study is important because
it specifically investigated the impact of extent of resection on
both short- and long-term outcomes, as well as assessed the
influence of resection extent relative to margin width using
both unadjusted and PSM analyses. Of note, extent of hepatic
resection did not impact OS among patients with a wider
Table 3 Univariate and
multivariable analysis of risk
factors associated with overall
survival of ICC patients (n = 963)
after exclusion of 90-day
mortality in Cox hazard
regression model
Variables Univariate analysis Multivariate analysis
HR (95% CI) p value HR (95% CI) p value
Sex (male/female) 0.9 (0.7–1.1) 0.209
Age (>55/≤55 years) 0.9 (0.8–1.1) 0.518
Tumor size (cm)
≤5 Reference Reference
5–10 1.8 (1.4–2.2) <0.001 1.0 (0.6–1.4) 0.991
≥10 1.8 (1.4–2.4) <0.001 1.0 (0.6–1.8) 0.845
Multiple tumors 2.0 (1.6–2.5) <0.001 1.5 (0.9–2.2) 0.088
Bilobar 1.4 (1.1–1.7) 0.006 1.0 (0.7–1.5) 0.985
Vascular invasion 1.6 (1.2–2.2) <0.001 1.3 (0.8–2.2) 0.354
Perineural invasion 1.4 (1.1–1.8) 0.013 1.3 (0.9–1.9) 0.401
Biliary invasion 1.5 (1.1–1.9) 0.004 0.9 (0.6–1.3) 0.325
Direct invasion of adjacent organs 2.4 (1.7–3.2) <0.001 1.1 (0.7–2.6) 0.619
Satellite lesions 2.1 (1.7–2.6) <0.001 1.0 (0.6–1.5) 0.924
Lymph nodes metastasis 3.2 (2.5–4.2) <0.001 2.8 (2.0–4.0) <0.001
Poor to undifferentiated 1.6 (1.3–2.1) <0.001 2.0 (1.4–2.9) <0.001
Major hepatectomy 1.2 (1.0–1.5) 0.058 1.0 (0.6–1.7) 0.908
Margin width (mm)
≥10 Reference Reference
5–9 1.0 (0.8–1.3) 0.966 1.2 (0.7–2.0) 0.557
1–4 1.3 (1.1–1.7) 0.016 1.9 (1.1–3.3) 0.016
<1 1.7 (1.3–2.4) 0.001 1.9 (1.2–3.2) 0.007
Intraoperative blood transfusion 2.1 (1.8–2.6) <0.001 1.5 (1.1–2.2) 0.024
Postoperative blood transfusion 1.5 (1.1–2.0) 0.015 1.3 (0.8–2.0) 0.321
Postoperative morbidity 0.344
No complication Reference
Clavien-Dindo grade I-II 1.0 (0.8–1.2)
Clavien-Dindo grade III- IV 1.2 (0.9–1.6)
P values from the multivariable models which are significant are in italics
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surgical margin (≥5 mm). Therefore, the findings of the pres-
ent study suggest that a radical resection with parenchymal
preservation should be recommended whenever possible, as
long as an adequate margin width (≥5 mm) can be achieved.
A major hepatectomy has been advocated for HCC tumors
>5 cm, as a more extensive resection allows for removal of a
wider surgical margin, as well as any microscopic disease
along the portal tributaries.27 Because a large portion of the
resected liver is typically occupied by the large tumor mass,
loss of functional liver parenchyma is typically minimal com-
pared with major hepatectomy for small HCC.26 For small
HCC (<5 cm), the role of major hepatectomy remains
controversial.26,28–30 In fact, several studies have noted that
preservation of liver parenchyma should take priority, and
minor hepatectomy can provide equal OS and RFS compared
with major hepatectomy for small HCC.16,31 For patients with
CRLM, several studies have noted that the extent of hepatec-
tomy is not associated with outcomes, with most studies fa-
voring parenchymal-sparing operations for CRLM.13,18,32,33
In the current study specifically investigating ICC patients, ma-
jor hepatectomy was performed in the majority (59%), includ-
ing hemihepatectomy (36%) or extended hemihepatectomy
(22%). Of note, the utilization of major hepatectomy for ICC
was higher than that reported in many studies on HCC (5–
39%).26,34 The reason for this is likely multifactorial and may
be related to the more aggressive nature of ICC and the infre-
quency of liver cirrhosis (10%), which allowed for more major
resections without the fear of liver insufficiency.
Notably, almost one half of the patients (48.4%) un-
dergoing major resection experienced a postoperative
complication versus only 27% of patients who
underwent a minor resection. Of note, one fourth of
patients had a severe complication (CDC ≥III) after a
major hepatectomy.
The occurrence of a postoperative complication has pre-
viously been reported to be an independent predictor of
worse long-term outcomes.35 In the current study, after ex-
clusion of patients who died within 90 days following
Table 4 Univariate and
multivariable analysis of risk
factors associated with
recurrence-free survival of ICC
patients (n = 963) after exclusion
of 90-day mortality in Cox hazard
regression model
Variables Univariate analysis Multivariate analysis
HR (95% CI) p value HR (95% CI) p value
Sex (male/female) 1.0 (0.8–1.2) 0.986
Age (>55/≤55 years) 0.8 (0.7–0.9) 0.005 0.7 (0.5–0.9) 0.012
Tumor size (cm)
≤5 Reference Reference
5–10 1.9 (1.5–2.3) <0.001 1.3 (0.8–2.2) 0.322
≥10 2.0 (1.5–2.6) <0.001 1.5 (1.0–2.2) 0.030
Multiple tumors 1.8 (1.5–2.2) <0.001 1.7 (1.2–2.4) 0.007
Bilobar 1.2 (0.9–1.4) 0.152
Vascular invasion 1.3 (1.0–1.7) 0.023 1.6 (1.0–2.5) 0.062
Perineural invasion 1.4 (1.1–1.7) 0.006 1.9 (1.3–2.6) <0.001
Biliary invasion 1.3 (1.0–1.6) 0.070 1.0 (0.7–1.4) 0.910
Direct invasion of adjacent organs 1.6 (1.2–2.3) 0.002 1.4 (0.8–2.4) 0.191
Satellite lesions 2.0 (1.6–2.3) <0.001 1.0 (0.7–1.4) 0.869
Lymph nodes metastasis 2.0 (1.6–2.6) <0.001 1.6 (1.2–2.2) 0.003
Poor to undifferentiated 1.4 (1.2–1.7) 0.001 1.4 (1.0–1.9) 0.062
Major hepatectomy 1.1 (1.0–1.4) 0.121
Margin width (mm)
≥10 Reference Reference
5–9 1.2 (0.9–1.5) 0.162 1.4 (0.9–2.2) 0.107
1–4 1.4 (1.1–1.7) 0.005 1.5 (1.0–2.2) 0.069
<1 1.7 (1.3–2.2) <0.001 1.6 (1.0–2.5) 0.061
Intraoperative blood transfusion 1.6 (1.3–1.9) <0.001 1.4 (1.0–2.0) 0.030




III- IV 1.1 (0.9–1.4)
P values from the multivariable models which are significant are in italics
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surgery, postoperative complications were not independent-
ly associated with either OS or RFS. Examination of the
Kaplan-Meier curves suggested that the impact of major
complications on survival was primarily in the immediate
post-operative period rather than in the long term. These
data suggest that the increased complications associated
with major hepatectomy may have an adverse short-term
effect on mortality risk.
When matched for tumor characteristics, surgical margin
width, postoperative complications, and mortality, patients
Fig. 2 Overall survival (OS) and recurrence-free survival (RFS) of patients undergoing major and minor hepatectomy with surgical margin ≥10mm (a),
5–9 mm (b), and 1–4 mm (c) after propensity score matching
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who underwent major hepatectomy had a comparable OS and
RFS compared with patients undergoing minor resection. Our
previous work had demonstrated that surgical margin width
was associated with long-term outcomes.8 Interestingly, in the
current study, patients undergoing major hepatectomy were
more likely to have an R1 margin. This finding might be
explained by the fact that patients with larger and more diffi-
cult tumors more frequently underwent a major resection.
However, among patients who had an R0 resection, surgical
margin width was not different for patients undergoing a ma-
jor versus minor resection. On subgroups analysis stratifying
patients according to margin width, patients undergoing major
resection had similar outcomes to patients undergoing minor
resection, as long as the surgical margin was wider than 5 mm.
In contrast, when the surgical margin was narrow (1–4 mm),
major resection was associated with a decrease in tumor re-
currence compared with minor resection. One possible expla-
nation is that ICC arises from intrahepatic biliary ducts and
tends to disseminate into the portal venous system. Major
hepatectomy may be more likely to remove the entire unilobar
portal venous drainage of the involved lobe of the liver.
However, unlike HCC, ICC mostly originates in a non-
cirrhotic liver and is therefore less likely to be multi-centric.
As such, the potential superiority of major hepatectomy in
eradicating microscopic metastatic lesions might be less when
the surgical margin is adequate (≥5 mm). However, when the
closest margin of tumor is narrow (<5 mm), major hepatecto-
my may have an effect of eradicating microscopic metastatic
lesions as evidenced by decreased tumor recurrence.
There were several limitations of the current study. First,
as a retrospective study, there was selection bias regarding
patients undergoing major or minor resection. To mitigate
this bias, we utilized PSM to create groups that were well-
match on known prognostic risk factors (e.g., tumor size,
number, vascular invasion, surgical margin, and postopera-
tive morbidity). We were also unable to discern Btrue^ ana-
tomic versus non-anatomic resections at the sub-lobar level,
as strict anatomic segmentectomy is not commonly per-
formed in most institutions. Therefore, it was not possible
to define and compare all Btrue^ anatomic and non-
anatomic resections.
In conclusion, extent of liver resection was not a driving
factor affecting long-term outcome of patients with ICC.
However, tumor factors and surgical margin impacted
long-term outcomes. Importantly, major hepatectomy was
associated with increased perioperative mortality and mor-
bidity. Taken together, the data suggest that major hepatec-
tomy for ICC does not provide a survival benefit, yet is
associated with increased perioperative morbidity. Margin
width, rather than the extent of resection, did impact long-
term outcomes, and radical parenchymal-sparing resection
should be advocated if a margin clearance of ≥5 mm can be
achieved.
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